EUVIMEDEUVIMED entdecken
Leitlinie

Preexposure Prophylaxis to Prevent Acquisition of HIV

US Preventive Services Task Force, Michael J Barry, Wanda K Nicholson, Michael Silverstein, David Chelmow, Tumaini Rucker Coker, Esa M Davis, Katrina E Donahue, Carlos Roberto Jaén, Marti Kubik, Li Li, Gbenga Ogedegbe und 6 weitere

JAMA · 2023

DOI: 10.1001/jama.2023.14461 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JAMA, 2023. Verfasst von US Preventive Services Task Force und 17 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Anti-Retroviral Agents, HIV Infections, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance An estimated 1.2 million persons in the US currently have HIV, and more than 760 000 persons have died of complications related to HIV since the first cases were reported in 1981. Although treatable, HIV is not curable and has significant health consequences. Therefore, effective strategies to prevent HIV are an important public health and clinical priority. Objective The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of preexposure prophylaxis with antiretroviral therapy for the prevention of HIV acquisition, and the diagnostic accuracy of risk assessment tools to identify persons at increased risk of HIV acquisition. Population Adolescents and adults who do not have HIV and are at increased risk of HIV. Evidence Assessment The USPSTF concludes with high certainty that there is a substantial net benefit from the use of effective antiretroviral therapy to reduce the risk of acquisition of HIV in persons at increased risk of acquiring HIV. Recommendation The USPSTF recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons at increased risk of HIV acquisition to decrease the risk of acquiring HIV. (A recommendation)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Retroviral AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultHumansAdvisory CommitteesPreventive Health ServicesPublic HealthRisk AssessmentUnited States

Substanzen

Anti-Retroviral Agents

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts.
  • George Washington University, Washington, DC.
  • Brown University, Providence, Rhode Island.
  • Virginia Commonwealth University, Richmond.
  • University of Washington, Seattle.
  • University of Maryland School of Medicine, Baltimore.

Zitieren

APA

US Preventive Services Task Force, Barry, M. J., Nicholson, W. K., Silverstein, M., Chelmow, D., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., Kubik, M., Li, L., Ogedegbe, G., Rao, G., Ruiz, J. M., Stevermer, J. J., Tsevat, J., Underwood, S. M., & Wong, J. B. (2023). Preexposure Prophylaxis to Prevent Acquisition of HIV. JAMA. https://doi.org/10.1001/jama.2023.14461

Vancouver

US Preventive Services Task Force, Barry MJ, Nicholson WK, Silverstein M, Chelmow D, Coker TR, et al. Preexposure Prophylaxis to Prevent Acquisition of HIV. JAMA. 2023. doi:10.1001/jama.2023.14461

BibTeX
@article{USPreventiveServicesTaskForce2023,
  author = {US Preventive Services Task Force, US Preventive Services Task Force and Barry, Michael J and Nicholson, Wanda K and Silverstein, Michael and Chelmow, David and Coker, Tumaini Rucker and Davis, Esa M and Donahue, Katrina E and Jaén, Carlos Roberto and Kubik, Marti and Li, Li and Ogedegbe, Gbenga and Rao, Goutham and Ruiz, John M and Stevermer, James J and Tsevat, Joel and Underwood, Sandra Millon and Wong, John B},
  title = {Preexposure Prophylaxis to Prevent Acquisition of HIV},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.14461}
}
Kostenlos starten →